Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions

被引：0
|
作者：
C Phipps
M T Lupo-Stanghellini
M E D Flowers
机构：
[1] Fred Hutchinson Cancer Research Center,Division of Clinical Research
[2] Singapore General Hospital,Department of Haematology
[3] Hematology and Bone Marrow Transplantation Unit,undefined
[4] San Raffaele Scientific Institute,undefined
来源：
Bone Marrow Transplantation | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：315 / 316
页数：1
相关论文
共 50 条
  • [1] Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions
    Phipps, C.
    Lupo-Stanghellini, M. T.
    Flowers, M. E. D.
    BONE MARROW TRANSPLANTATION, 2014, 49 (02) : 315 - 316
  • [2] TREATMENT OF REFRACTORY SCLERODERMATOUS GRAFT-VERSUS-HOST DISEASE WITH ETRETINATE
    MARCELLUS, DC
    FREEMER, CS
    FARMER, EB
    ALTOMONTE, V
    VOGELSANG, GB
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1106 - 1106
  • [3] Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease
    Marcellus, DC
    Altomonte, VL
    Farmer, ER
    Horn, TD
    Freemer, CS
    Grant, J
    Vogelsang, GB
    BLOOD, 1999, 93 (01) : 66 - 70
  • [4] Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease
    Yakoub-Agha, Ibrahim
    Magro, Leonardo
    Catteau, Benoit
    Willekens, Christophe
    Coiteux, Valerie
    Bruno, Benedicte
    Terriou, Louis
    Jouet, Jean-Pierre
    BLOOD, 2008, 112 (11) : 745 - 746
  • [5] CHRONIC SCLERODERMATOUS GRAFT-VERSUS-HOST DISEASE
    MULLERSERTEN, B
    VAKILZADEH, F
    HAUTARZT, 1994, 45 (11): : 772 - 775
  • [6] Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease
    Hurabielle, C.
    de Fontbrune, F. Sicre
    Moins-Teisserenc, H.
    Robin, M.
    Jachiet, M.
    Coman, T.
    Dhedin, N.
    Cassius, C.
    Chasset, F.
    de Masson, A.
    Michonneau, D.
    Bagot, M.
    Bergeron, A.
    Socie, G.
    de Latour, R. Peffault
    Bouaziz, J-D
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E206 - E208
  • [7] Hedgehog blockade in the treatment of steroid-refractory sclerodermatous chronic graft-versus-host disease
    Radojcic, Vedran
    Lee, Catherine
    Pletneva, Maria
    Hicks, Kolleen
    Sarantopoulos, Stefanie
    Couriel, Daniel
    BONE MARROW TRANSPLANTATION, 2019, 54 : 305 - 306
  • [8] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
    Namdaroglu, S.
    Iskender, D.
    Dal, M. S.
    Cakar, M. K.
    Tekgunduz, E.
    Altuntas, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
  • [9] Imatinib mesylate in the treatment of sclerodermatous chronic graft-versus-host disease
    Yakoub-Agha, I.
    Magro, L.
    Catteau, B.
    Coiteux, V.
    Terriou, L.
    Jouet, J. P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S190 - S190
  • [10] Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
    M Okamoto
    A Okano
    S Akamatsu
    E Ashihara
    T Inaba
    H Takenaka
    N Katoh
    S Kishimoto
    C Shimazaki
    Leukemia, 2006, 20 : 172 - 173
12345